Seaport Global Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,898
Closed -$2.9M 64
2024
Q1
$2.9M Buy
8,898
+5,245
+144% +$1.29M 5.88% 3
2023
Q4
$696K Buy
3,653
+2,895
+382% +$547K 1.67% 25
2023
Q3
$151K Buy
758
+168
+28% +$39.7K 0.45% 69
2023
Q2
$168K Sell
590
-394
-40% -$109K 0.5% 74
2023
Q1
$213K Sell
984
-632
-39% -$123K 0.67% 59
2022
Q4
$332K Buy
+1,616
New +$409K 1.15% 30

Other funds holding SWAV

Seaport Global Advisors's SWAV Position: Q2 2024 in Review

Seaport Global Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 8,898 shares — an estimated $2.9M sold.

Seaport Global Advisors first reported a position in SWAV in Q4 2022 and held it in 6 quarters. The position peaked at $2.9M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Seaport Global Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Seaport Global Advisors sold 8,898 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $2.9M.
  • Seaport Global Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Seaport Global Advisors's Shockwave Medical, Inc. Common Stock position peaked at $2.9M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Seaport Global Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.